185 related articles for article (PubMed ID: 20947388)
1. Peripheral MRA with k-space segmentation and blood-pool contrast agent.
Kinner S; Zenge MO; Heilmaier C; de Greiff A; Vogt FM; Ladd ME; Barkhausen J; Quick HH
Acad Radiol; 2011 Jan; 18(1):113-9. PubMed ID: 20947388
[TBL] [Abstract][Full Text] [Related]
2. Highly accelerated first-pass contrast-enhanced magnetic resonance angiography of the peripheral vasculature: comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents.
Maki JH; Wang M; Wilson GJ; Shutske MG; Leiner T
J Magn Reson Imaging; 2009 Nov; 30(5):1085-92. PubMed ID: 19856442
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease.
Nielsen YW; Eiberg JP; Løgager VB; Just S; Schroeder TV; Thomsen HS
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):484-91. PubMed ID: 19957180
[TBL] [Abstract][Full Text] [Related]
4. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
[TBL] [Abstract][Full Text] [Related]
5. Post-processing central k-space subtraction for high-resolution arterial peripheral MR angiography.
Gedat E; Mohajer M; Kirsch R; Frericks B
Magn Reson Imaging; 2011 Jul; 29(6):835-43. PubMed ID: 21546189
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
[TBL] [Abstract][Full Text] [Related]
7. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience.
Nikolaou K; Kramer H; Grosse C; Clevert D; Dietrich O; Hartmann M; Chamberlin P; Assmann S; Reiser MF; Schoenberg SO
Radiology; 2006 Dec; 241(3):861-72. PubMed ID: 17032914
[TBL] [Abstract][Full Text] [Related]
8. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA.
Bonel HM; Saar B; Hoppe H; Keo HH; Husmann M; Nikolaou K; Ludwig K; Szucs-Farkas Z; Srivastav S; Kickuth R
Radiology; 2009 Dec; 253(3):879-90. PubMed ID: 19864508
[TBL] [Abstract][Full Text] [Related]
9. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
[TBL] [Abstract][Full Text] [Related]
10. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
[TBL] [Abstract][Full Text] [Related]
11. Advantages of blood pool contrast agents in MR angiography: a pictorial review.
Lewis M; Yanny S; Malcolm PN
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):187-91. PubMed ID: 22498192
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MR angiography in patients with peripheral arterial disease.
Nielsen YJ
Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
[TBL] [Abstract][Full Text] [Related]
13. First-pass and steady-state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium.
Naehle CP; Müller A; Willinek WA; Meyer C; Hestermann T; Gieseke J; Schild H; Thomas D
J Magn Reson Imaging; 2009 Oct; 30(4):809-16. PubMed ID: 19787726
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography.
Berg F; Bangard C; Bovenschulte H; Hellmich M; Nijenhuis M; Lackner K; Gossmann A
Invest Radiol; 2008 Sep; 43(9):642-9. PubMed ID: 18708858
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium.
Nielsen YW; Eiberg JP; Løgager VB; Hansen MA; Schroeder TV; Thomsen HS
Acad Radiol; 2009 Jun; 16(6):654-61. PubMed ID: 19297207
[TBL] [Abstract][Full Text] [Related]
16. 0.125 mm(3) spatial resolution steady-state MR angiography of the thighs with a blood pool contrast agent using the quadrature body coil only at 1.5 Tesla.
Boschewitz JM; Hadizadeh DR; Kukuk GM; Meyer C; Wilhelm K; Koscielny A; Verrel F; Gieseke J; Schild HH; Willinek WA
J Magn Reson Imaging; 2014 Oct; 40(4):996-1001. PubMed ID: 24845363
[TBL] [Abstract][Full Text] [Related]
17. Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium--a feasibility study.
Wagner M; Rief M; Asbach P; Vogtmann T; Huppertz A; Beling M; Butler C; Laule M; Warmuth C; Taupitz M; Hamm B; Lembcke A
Eur J Radiol; 2010 Aug; 75(2):166-72. PubMed ID: 19464133
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
Pfeil A; Betge S; Poehlmann G; Boettcher J; Drescher R; Malich A; Wolf G; Mentzel HJ; Hansch A
Eur J Radiol; 2012 Mar; 81(3):547-52. PubMed ID: 21349675
[TBL] [Abstract][Full Text] [Related]
19. A multi-center, comparative, phase 3 study to determine the efficacy of gadofosveset-enhanced magnetic resonance angiography for evaluation of renal artery disease.
McGregor R; Vymazal J; Martinez-Lopez M; Neuwirth J; Salgado P; Beregi JP; Peduto A; de la Pena-Almaguer E; Slater GJ; Shamsi K; Parsons EC
Eur J Radiol; 2008 Feb; 65(2):316-25. PubMed ID: 17499952
[TBL] [Abstract][Full Text] [Related]
20. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
